Fumio Kumano

552 citations
6 papers · 453 indexed · h-index 6
Topics
Osteoarthritis Treatment and Mechanisms (5 papers)Proteoglycans and glycosaminoglycans research (3 papers)Spine and Intervertebral Disc Pathology (2 papers)
Partner nations
JapanUnited States

In The Last Decade

Fumio Kumano

6 papers receiving 435 citations

Peers

Fumio Kumano
Comparison fields: 5 of 59
  • Pathology and Forensic Medicine 209
  • Pharmacology 179
  • Rheumatology 178
  • Surgery 156
  • Cell Biology 108
Replace Jeanette Libera with:
Jeanette Libera Germany
B.J. Grimmer Canada
Hideki Nakamoto Japan
Zariel I. Johnson United States
Eugene J-M.A. Thonar United States
Lawrence M. Boyd United States
Bhaloo J. Desai United States
L. Rappoport United States
Lori Otten United States
Fumio Kumano relative to Jeanette Libera Germany Jeanette Libera's profile →
Citations per field
00.5×
Jeanette Libera · 1×
Citations per year

Countries citing papers authored by Fumio Kumano

Since Specialization
Citations

This map shows the geographic impact of Fumio Kumano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Kumano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Kumano more than expected).

Fields of papers citing papers by Fumio Kumano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Kumano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Kumano. The network helps show where Fumio Kumano may publish in the future.

Co-authorship network of co-authors of Fumio Kumano

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Kumano. A scholar is included among the top collaborators of Fumio Kumano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Kumano. Fumio Kumano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 85
2 145
3 44
4 61
5 75
6 43

About Fumio Kumano

Fumio Kumano is a scholar working on Rheumatology, Cell Biology and Immunology and Allergy, having authored 6 papers that have together received 453 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (5 papers), Proteoglycans and glycosaminoglycans research (3 papers) and Spine and Intervertebral Disc Pathology (2 papers). The work is most often cited by research in Rheumatology (178 citations), Pathology and Forensic Medicine (209 citations) and Pharmacology (179 citations). Fumio Kumano has collaborated with scholars based in Japan and United States. Frequent co-authors include Kanji Fukuda, Kazuhiro Chiba, Howard S. An, Koichi Masuda, S Tanaka, Eugene J-M.A. Thonar, Thomas Schmid, Gunnar B. J. Andersson, Shigeki Asada and Kazuhiro Otani. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Orthopaedic Research® and The Spine Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026